Should we add screening for and treating left ventricular hypertrophy to the management of all patients needing secondary prevention of cardiovascular disease?

A.D. Struthers; J. Davies

doi:10.1093/qjmed/hcg067

Should we add screening for and treating left ventricular hypertrophy to the management of all patients needing secondary prevention of cardiovascular disease?

A.D. Struthers
, J. Davies

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	449-452
Number of pages	4
Journal	QJM : an International Journal of Medicine
Volume	96
Issue number	6
DOIs	https://doi.org/10.1093/qjmed/hcg067
Publication status	Published - Jun 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/qjmed/hcg067

http://qjmed.oxfordjournals.org/content/96/6/449.full

Cite this

@article{8b9adea7d15542d5badc46e1c9edfc7c,

title = "Should we add screening for and treating left ventricular hypertrophy to the management of all patients needing secondary prevention of cardiovascular disease?",

author = "A.D. Struthers and J. Davies",

year = "2003",

month = jun,

doi = "10.1093/qjmed/hcg067",

language = "English",

volume = "96",

pages = "449--452",

journal = "QJM : an International Journal of Medicine",

issn = "1460-2725",